Ginkgo biloba extract EGb 761® in the symptomatic treatment of mild-to-moderate dementia: a profile of its use

[1]  A. Wąsik,et al.  The mechanism of neuroprotective action of natural compounds , 2017, Pharmacological reports : PR.

[2]  A. Sanabria-Castro,et al.  Molecular Pathogenesis of Alzheimer's Disease: An Update , 2017, Annals of Neurosciences.

[3]  A. Abd El-moneim,et al.  Ginkgo biloba extract alleviates oxidative stress and some neurotransmitters changes induced by aluminum chloride in rats. , 2017, Nutrition.

[4]  C. Kirschbaum,et al.  Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective memory impairment – a randomized double‐blind placebo‐controlled trial , 2016, Human psychopharmacology.

[5]  Feng Wu,et al.  Protection Efficacy of the Extract of Ginkgo biloba against the Learning and Memory Damage of Rats under Repeated High Sustained +Gz Exposure , 2016, Evidence-based complementary and alternative medicine : eCAM.

[6]  Seol-Heui Han,et al.  Ginkgo biloba extract (Egb761) attenuates zinc-induced tau phosphorylation at Ser262 by regulating GSK3β activity in rat primary cortical neurons. , 2015, Food & function.

[7]  M. Mochizuki,et al.  Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia , 2015, Journal of pharmaceutical health care and sciences.

[8]  W. Gaus,et al.  Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract. , 2015, Toxicology.

[9]  S. Gauthier,et al.  Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials , 2014, Clinical interventions in aging.

[10]  L. Tan,et al.  Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. , 2014, Journal of Alzheimer's disease : JAD.

[11]  M. Cesari,et al.  Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: data from the ICTUS study. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  A. de Silvestri,et al.  A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine , 2013, Evidence-based complementary and alternative medicine : eCAM.

[13]  M. Schubert-Zsilavecz,et al.  Ginkgo biloba Extracts: A Review of the Pharmacokinetics of the Active Ingredients , 2013, Clinical Pharmacokinetics.

[14]  Chunbo Li,et al.  Ginkgo biloba extract for dementia: a systematic review , 2013, Shanghai archives of psychiatry.

[15]  D. Geng,et al.  Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia , 2012, Journal of biomedical research.

[16]  Jian-min Li,et al.  [Effects of extract of ginkgo biloba on learning and memory ability and NGF and NT-3 expression in diabetic rats]. , 2012, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology.

[17]  R. Hoerr,et al.  Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. , 2012, Journal of psychiatric research.

[18]  J. Klein,et al.  Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. , 2012, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[19]  R. Ihl,et al.  Efficacy and Tolerability of a Once Daily Formulation of Ginkgo biloba Extract EGb 761® in Alzheimer’s Disease and Vascular Dementia: Results from a Randomised Controlled Trial , 2011, Pharmacopsychiatry.

[20]  M. Rocher,et al.  Long-term treatment with standardized Ginkgo biloba extract (EGb 761) attenuates cognitive deficits and hippocampal neuron loss in a gerbil model of vascular dementia. , 2011, Fitoterapia.

[21]  R. Silberstein,et al.  Examining Brain-Cognition Effects of Ginkgo Biloba Extract: Brain Activation in the Left Temporal and Left Prefrontal Cortex in an Object Working Memory Task , 2011, Evidence-based complementary and alternative medicine : eCAM.

[22]  Alan J. Thomas,et al.  Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.

[23]  R. Ihl,et al.  Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial , 2010, International journal of geriatric psychiatry.

[24]  M. Hamburger,et al.  Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues Aβ-Induced Failure , 2010, PloS one.

[25]  S. Yan,et al.  Role of mitochondrial amyloid-beta in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[26]  Jie Xu,et al.  Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. , 2009, Chemico-biological interactions.

[27]  O. Napryeyenko,et al.  Efficacy and tolerability of Ginkgo biloba extract EGb 761® by type of dementia: Analyses of a randomised controlled trial , 2009, Journal of Neurological Sciences.

[28]  R. Ihl,et al.  Ginkgo biloba extract EGb 761®, donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: A randomised, double-blind, exploratory trial , 2009, Aging & mental health.

[29]  W. Gaus.  An example for an underpowered study: a comment on Ginkgo biloba for mild to moderate dementia in a community setting by McCarney et al. , 2009, International journal of geriatric psychiatry.

[30]  S. Iliffe,et al.  Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel‐group, double‐blind, placebo‐controlled trial , 2008, International journal of geriatric psychiatry.

[31]  J. Zehnder,et al.  Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[32]  Y. Christen,et al.  EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  O. Napryeyenko,et al.  Ginkgo biloba Special Extract in Dementia with Neuropsychiatric Features , 2007, Arzneimittelforschung.

[34]  Y. Christen,et al.  Protection by EGb 761 against β-amyloid-induced neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation , 2006 .

[35]  H. Milani,et al.  Sustained neuroprotection and facilitation of behavioral recovery by the Ginkgo biloba extract, EGb 761, after transient forebrain ischemia in rats , 2006, Behavioural Brain Research.

[36]  P. Bria,et al.  Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study , 2006, European journal of neurology.

[37]  Jing Wu,et al.  The in vivo synaptic plasticity mechanism of EGb 761‐induced enhancement of spatial learning and memory in aged rats , 2006, British journal of pharmacology.

[38]  S. Robbins,et al.  Effects of Ginkgo biloba administered after spatial learning on water maze and radial arm maze performance in young adult rats , 2006, Pharmacology Biochemistry and Behavior.

[39]  Meinhard Kieser,et al.  A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. , 2005, Current Alzheimer research.

[40]  V. Papadopoulos,et al.  Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels. , 2004, The Journal of nutritional biochemistry.

[41]  D. Westaway,et al.  Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. , 2004, Journal of psychiatry & neuroscience : JPN.

[42]  P. Schultz,et al.  Age-related effects of Ginkgo biloba extract on synaptic plasticity and excitability , 2004, Neurobiology of Aging.

[43]  Y. Christen,et al.  Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts , 2004, Neurobiology of Disease.

[44]  R. Stackman,et al.  Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment , 2003, Experimental Neurology.

[45]  S. Kanowski,et al.  Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. , 2003, Pharmacopsychiatry.

[46]  B. Ahlemeyer,et al.  Neuroprotective effects of Ginkgo biloba extract , 2003, Cellular and Molecular Life Sciences CMLS.

[47]  L. Drouet,et al.  No alteration in platelet function or coagulation induced by EGb761 in a controlled study. , 2003, Clinical and laboratory haematology.

[48]  G. Fiskum,et al.  Neuroprotective Effects of Bilobalide, a Component of Ginkgo biloba Extract (EGb 761®) in Global Brain Ischemia and in Excitotoxicity-induced Neuronal Death , 2003 .

[49]  P. Knipschild,et al.  Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.

[50]  F. V. Defeudis,et al.  Bilobalide and neuroprotection. , 2002, Pharmacological research.

[51]  B. Schug,et al.  Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations , 2002, The Journal of pharmacy and pharmacology.

[52]  P. Butko,et al.  Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Quirion,et al.  EGb 761 is a neuroprotective agent against beta-amyloid toxicity. , 2002, Cellular and molecular biology.

[54]  Y. Christen,et al.  The Ginkgo biloba extract EGb 761 increases viability of hnt human neurons in culture and affectsthe expression of genes implicated in the stress response. , 2002, Cellular and molecular biology.

[55]  Paul F. Smith,et al.  The CNS effects of Ginkgo biloba extracts and ginkgolide B , 2002, Progress in Neurobiology.

[56]  H. Blume,et al.  Pharmaceutical quality of different Ginkgo biloba brands , 2002, The Journal of pharmacy and pharmacology.

[57]  A. Henriques,et al.  The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats , 2001, Phytotherapy research : PTR.

[58]  V. Papadopoulos,et al.  The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2001, Brain Research.

[59]  P. Knipschild,et al.  The Efficacy of Ginkgo for Elderly People with Dementia and Age‐Associated Memory Impairment: New Results of a Randomized Clinical Trial , 2000, Journal of the American Geriatrics Society.

[60]  F. V. Defeudis,et al.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.

[61]  K. Z. Itil,et al.  A 26-Week Analysis of a Double-Blind, Placebo-Controlled Trial of the Ginkgo biloba Extract EGb 761® in Dementia , 2000, Dementia and Geriatric Cognitive Disorders.

[62]  V. Papadopoulos,et al.  The Ginkgo biloba extract EGB 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2000, Neurobiology of Aging.

[63]  T. Wei,et al.  Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: protection by Ginkgo biloba extract. , 2000, Pharmacological research.

[64]  J. C. Winter,et al.  The Effects of an Extract of Ginkgo biloba, EGb 761, on Cognitive Behavior and Longevity in the Rat , 1998, Physiology & Behavior.

[65]  J. Sastre,et al.  A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress. , 1998, Free radical biology & medicine.

[66]  R. Ihl,et al.  Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. , 1997, Journal of psychiatric research.

[67]  Turan M. Itil,et al.  A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .

[68]  A. Schatzberg,et al.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.

[69]  W. Herrmann,et al.  Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. , 1996, Pharmacopsychiatry.

[70]  M. Lacour,et al.  Pharmacological activity of the Ginkgo biloba extract (EGb 761) on equilibrium function recovery in the unilateral vestibular neurectomized cat. , 1995, Journal of vestibular research : equilibrium & orientation.

[71]  D. Westaway,et al.  Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease , 2004 .

[72]  Yuan Luo,et al.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.